GLAUKOS Corp
GLAUKOS Corp
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 114 | 104 | 91 | 98 | 101 | 114 | 170 | 100 | 68 | 42 | 93 | 109 | |||||
Available For Sale Securities Debt Securities | 172 | 172 | 188 | 175 | 174 | 184 | 149 | 162 | 194 | 230 | 202 | 192 | |||||
Accounts Receivable Net Current | 139 | 120 | 109 | 99 | 83 | 72 | 61 | 56 | 51 | 47 | 40 | 39 | |||||
Inventory Net | 59 | 62 | 64 | 64 | 65 | 59 | 58 | 60 | 56 | 50 | 42 | 40 | |||||
Prepaid Expense And Other Assets Current | 31 | 27 | 24 | 19 | 14 | 15 | 12 | 19 | 14 | 19 | 18 | 20 | |||||
Assets Current | 516 | 486 | 475 | 455 | 436 | 445 | 450 | 397 | 384 | 389 | 395 | 400 | |||||
Restricted Cash And Cash Equivalents Noncurrent | 3 | 4 | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | |||||
Property Plant And Equipment Net | 112 | 112 | 113 | 111 | 112 | 97 | 98 | 99 | 100 | 102 | 103 | 103 | |||||
Operating Lease Right Of Use Asset | 31 | 31 | 32 | 32 | 32 | 32 | 30 | 27 | 26 | 27 | 27 | 27 | |||||
Finance Lease Right Of Use Asset | 38 | 39 | 39 | 40 | 41 | 41 | 42 | 42 | 43 | 44 | 44 | 45 | |||||
Intangible Assets Net Excluding Goodwill | 127 | 133 | 142 | 264 | 270 | 258 | 263 | 269 | 276 | 282 | 283 | 289 | |||||
Goodwill | 67 | 67 | 67 | 67 | 67 | 66 | 66 | 66 | 66 | 66 | 66 | 66 | |||||
Assets | 921 | 893 | 893 | 999 | 987 | 966 | 975 | 927 | 920 | 933 | 940 | 949 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 19 | 19 | 25 | 20 | 14 | 16 | 13 | 11 | 12 | 13 | 13 | 10 | |||||
Accrued Liabilities Current | 83 | 70 | 77 | 68 | 65 | 53 | 62 | 61 | 59 | 59 | 61 | 57 | |||||
Liabilities Current | 102 | 89 | 101 | 88 | 79 | 69 | 75 | 72 | 70 | 72 | 74 | 67 | |||||
Convertible Long Term Notes Payable | - | - | - | - | - | - | - | 57 | 57 | 283 | 283 | 282 | |||||
Operating Lease Liability Noncurrent | 35 | 35 | 36 | 36 | 36 | 36 | 34 | 31 | 30 | 30 | 30 | 31 | |||||
Finance Lease Liability Noncurrent | 67 | 68 | 68 | 68 | 69 | 69 | 69 | 70 | 70 | 70 | 71 | 71 | |||||
Deferred Income Tax Liabilities Net | 0 | 0 | 0 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | |||||
Other Liabilities Noncurrent | 32 | 29 | 32 | 31 | 31 | 21 | 22 | 22 | 21 | 20 | 14 | 13 | |||||
Liabilities | 238 | 222 | 237 | 230 | 222 | 202 | 208 | 258 | 255 | 483 | 479 | 471 | |||||
Stockholders Equity | |||||||||||||||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital Common Stock | 1,651 | 1,621 | 1,586 | 1,566 | 1,546 | 1,525 | 1,510 | 1,378 | 1,353 | 1,089 | 1,060 | 1,039 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 1 | 1 | 1 | |||||
Retained Earnings Accumulated Deficit | -971 | -953 | -933 | -799 | -783 | -764 | -745 | -712 | -690 | -640 | -599 | -562 | |||||
Treasury Stock Common Value | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | |||||
Stockholders Equity | 682 | 671 | 656 | 770 | 765 | 764 | 767 | 669 | 665 | 451 | 462 | 478 | |||||
Liabilities And Stockholders Equity | 921 | 893 | 893 | 999 | 987 | 966 | 975 | 927 | 920 | 933 | 940 | 949 | |||||
Preferred Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Common Stock Shares Authorized | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | |||||
Common Stock Shares Issued | 59 | 58 | 58 | 57 | 57 | 57 | 56 | 55 | 55 | 50 | 49 | 49 | |||||
Shares Outstanding | 59 | 58 | 58 | 57 | 57 | 57 | 56 | 55 | 55 | 50 | 49 | 49 | |||||
Treasury Stock Common Shares | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -16.32% | -9.04% | 9.16% | - | - | - | - | - | - | - | - | - |
| 2025 | 14.94% | 19.88% | 16.95% | 9.51% | -8.66% | -14.66% | 13.11% | 31.96% | 36.53% | -16.13% | 3.64% | 19.60% |
| 2024 | 2.23% | 6.11% | 13.35% | 14.53% | 10.13% | 14.94% | 12.35% | 18.22% | 25.31% | -15.14% | -25.10% | -20.78% |
| 2023 | - | - | - | -1.12% | 0.75% | -9.27% | -9.09% | 18.59% | 31.48% | -4.56% | 9.67% | 23.32% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 5.04 | 5.43 | 4.69 | 5.20 | 5.51 | 6.49 | 5.99 | 5.54 | 5.48 | 5.38 | 5.34 | 5.95 | |||||
| Quick Ratio | 4.15 | 4.43 | 3.82 | 4.26 | 4.52 | 5.40 | 5.05 | 4.45 | 4.46 | 4.42 | 4.53 | 5.07 | |||||
| Working Capital | 413.45M | 396.34M | 373.71M | 367.25M | 356.93M | 376.02M | 374.67M | 325.60M | 313.70M | 316.37M | 321.45M | 332.38M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.35 | 0.33 | 0.36 | 0.30 | 0.29 | 0.26 | 0.27 | 0.39 | 0.38 | 1.07 | 1.04 | 0.99 | |||||
| Interest Coverage TTM | -39.42 | -43.24 | -43.06 | -17.47 | -17.43 | -13.41 | -12.19 | -11.12 | -9.95 | -9.86 | -9.44 | -9.09 | |||||
| Debt Ratio | 0.26 | 0.25 | 0.27 | 0.23 | 0.22 | 0.21 | 0.21 | 0.28 | 0.28 | 0.52 | 0.51 | 0.50 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.64 | 0.59 | 0.54 | 0.49 | 0.45 | 0.43 | 0.40 | 0.38 | 0.36 | 0.34 | 0.32 | 0.31 | |||||
| Days Sales Outstanding TTM | 66.08 | 63.30 | 60.91 | 60.24 | 56.57 | 53.27 | 47.87 | 48.49 | 48.32 | 47.18 | 44.03 | 44.54 | |||||
| Receivables Turnover TTM | 5.52 | 5.77 | 5.99 | 6.06 | 6.45 | 6.85 | 7.62 | 7.53 | 7.55 | 7.74 | 8.29 | 8.19 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -3.20 | -3.26 | -3.28 | -1.53 | -1.62 | -2.18 | -2.77 | -2.72 | -3.13 | -2.84 | -2.78 | -2.66 | |||||
| Free Cash Flow Per Share TTM | -0.21 | -0.32 | -0.39 | -0.48 | -0.47 | -0.94 | -1.28 | -1.48 | -1.61 | -1.52 | -1.61 | -1.55 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 60.70% | 57.61% | 55.72% | 76.87% | 76.34% | 75.75% | 75.48% | 76.61% | 76.53% | 76.18% | 75.99% | 75.65% | |||||
| Operating Profit Margin TTM | -31.55% | -36.05% | -39.33% | -18.82% | -22.33% | -25.70% | -31.91% | -36.72% | -39.70% | -41.29% | -40.89% | -40.78% | |||||
| Net Profit Margin TTM | -30.68% | -34.34% | -36.99% | -18.65% | -21.43% | -30.57% | -38.17% | -41.51% | -46.41% | -43.16% | -42.79% | -42.61% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 41.55% | 36.30% | 32.33% | 30.38% | 26.70% | 23.92% | 21.85% | 18.70% | 15.14% | 12.92% | 11.26% | 6.56% | |||||
| Net Income Growth (1Y) | 102.66% | 53.08% | 28.23% | -41.42% | -41.50% | -12.20% | 8.70% | 15.64% | 25.41% | 1.20% | 35.75% | 44.34% | |||||
| EPS Growth (1Y) | 97.10% | 49.42% | 18.28% | -43.83% | -48.13% | -23.14% | -0.21% | 2.27% | 19.39% | -2.26% | 32.98% | 41.20% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -43.71 | -32.99 | -34.40 | -53.43 | -63.68 | -45.07 | -54.04 | -47.94 | -37.84 | -33.19 | -28.59 | -28.32 | |||||
| P/B TTM | 12.04 | 9.31 | 9.84 | 6.08 | 7.72 | 7.30 | 10.31 | 10.73 | 9.02 | 10.37 | 8.34 | 7.67 | |||||
| P/S TTM | 13.41 | 11.33 | 12.73 | 9.96 | 13.65 | 13.78 | 20.63 | 19.90 | 17.56 | 14.32 | 12.23 | 12.07 | |||||
| Market Cap | 8.22B | 6.25B | 6.46B | 4.68B | 5.91B | 5.57B | 7.91B | 7.17B | 6.00B | 4.67B | 3.85B | 3.66B | |||||
| Enterprise Value | 8.17B | 6.21B | 6.43B | 4.65B | 5.87B | 5.52B | 7.81B | 7.19B | 6.06B | 4.98B | 4.10B | 3.90B | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -12.20M | -18.48M | -22.46M | -27.61M | -26.92M | -53.24M | -67.62M | -81.27M | -81.76M | -75.17M | -78.01M | -75.48M | |||||
| Net Debt | -50.26M | -40.34M | -26.54M | -33.61M | -35.82M | -49.83M | -104.90M | 21.60M | 53.89M | 305.06M | 253.99M | 238.43M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
GLAUKOS Corp (GKOS) — SEC Financial Statements & Analysis
GLAUKOS Corp (GKOS) is a surgical & medical instruments & apparatus company, incorporated in DE. GLAUKOS Corp trades on NYSE as: GKOS. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), GLAUKOS Corp reported a 41.55% year-over-year revenue growth, a Gross Profit Margin of 60.70% (TTM), a Debt-to-Equity ratio of 0.35x, a Price-to-Sales (P/S) ratio of 13.41x (TTM), a Price-to-Book (P/B) ratio of 12.04x (TTM), at a market cap of $8.22B. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 41.55%
- Gross Profit Margin TTM
- 60.70%
- Debt To Equity
- 0.35x
- P/S TTM
- 13.41x
- P/B TTM
- 12.04x
- Market Cap
- $8.22B
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is GLAUKOS Corp in?
GLAUKOS Corp (GKOS) operates in the Surgical & Medical Instruments & Apparatus industry.
What is GKOS's market cap?
GLAUKOS Corp (GKOS) has a market capitalization of $8.22B as of 2026-06-30.
What exchange does GKOS trade on?
GLAUKOS Corp (GKOS) trades on the NYSE.
Where is GLAUKOS Corp incorporated?
GLAUKOS Corp is incorporated in DE.